| 9.20 Delayed Data As of Nov 13 |  -0.43 / -4.47%Today’s Change | 6.16 Today|||52-Week Range 14.98 | -15.67% Year-to-Date |
| ChemoCentryx Inc (CCXI) Q3 2019 Earnings Call Transcript Nov 04 / MotleyFool.com - Paid Partner Content |
| Previous close | 9.63 |
| Today’s open | 9.57 |
| Day’s range | 9.13 - 9.61 |
| Volume | 321,907 |
| Average volume (3 months) | 396,862 |
| Market cap | $565.2M |
| Earnings growth (last year) | -306.00% |
| Earnings growth (this year) | -26.32% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -48.03% |
| P/E ratio | NM |
| Price/Sales | 12.68 |
| Price/Book | 33.30 |
| Today’s change | Today’s % change | |
|---|---|---|
| BDSIBioDelivery Sciences... | +0.15 | +2.56% |
| AKROAkero Therapeutics I... | +0.12 | +0.64% |
| PGNXProgenics Pharmaceut... | +0.13 | +2.25% |
| CLLSCellectis SA | +0.01 | +0.08% |
| Next reporting date | March 12, 2020 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $42.9M |
| Annual profit (last year) | -$38.0M |
| Net profit margin | -88.55% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Mountain View, California |
